LuX. Structure and function of angiopoietin-like protein 3 (ANGPTL3) in atherosclerosis. Curr Med Chem. Epub ahead of print 22 June 2019. DOI: 10.2174/0929867326666190621120523.
2.
StitzielNOKheraAVWangX, et al.ANGPTL3 deficiency and protection against coronary artery disease. J Am Coll Cardiol2017; 69: 2054–2063.
3.
PisciottaLFavariEMagnoloL, et al.Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3. Circ Cardiovasc Genet2012; 5: 42–50.
4.
ZhangCCKabaMGeG, et al.Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med2006; 12: 240–245.
5.
RosselloXDorresteijnJAJanssenA, et al.Risk prediction tools in cardiovascular disease prevention: a report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). Eur J Prev Cardiol2019; 26: 1534–1544.
6.
MacchiCBanachMCorsiniA, et al.Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents. Eur J Prev Cardiol2019; 26: 930–949.
7.
CiceroAFRosticciMBoveM, et al.Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella Heart Study. Ann Med2017; 49: 275–282.
8.
MacchiCFerriNFaveroC, et al.Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individuals. Eur J Prev Cardiol2019; 26: 578–588.
9.
Van BortelLMLaurentSBoutouyrieP, et al.Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens2012; 30: 445–448.
10.
AboyansVCriquiMHAbrahamP, et al.Measurement and interpretation of the ankle–brachial index: a scientific statement from the American Heart Association. Circulation2012; 126: 2890–2909.
11.
SigvantBLundinFWahlbergE. The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg2016; 51: 395–403.
12.
Biondi-ZoccaiGFratiGGiordanoA, et al.Predicting incident peripheral artery disease and critical limb ischemia: feeling the pulse!. Eur J Prev Cardiol.. 2020; 27: 47–50.
13.
HajibandehSHajibandehSShahS, et al.Prognostic significance of ankle brachial pressure index: a systematic review and meta-analysis. Vascular2017; 25: 208–224.
14.
HatsudaSShojiTShinoharaK, et al.Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects. J Vasc Res2007; 44: 61–66.
15.
RuscicaMFerriNFogacciF, et al.Circulating levels of proprotein convertase subtilisin/kexin type 9 and arterial stiffness in a large population sample: data from the Brisighella Heart Study. J Am Heart Assoc2017; 6: e005764–e005764.
16.
LupoMGFerriN. Angiopoietin-like 3 (ANGPTL3) and atherosclerosis: lipid and non-lipid related effects. J Cardiovasc Dev Dis2018; 5: E39–E39.
